» Articles » PMID: 33505535

Identified GNGT1 and NMU As Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression

Overview
Journal Dis Markers
Publisher Wiley
Specialty Biochemistry
Date 2021 Jan 28
PMID 33505535
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Non-small-cell lung cancer (NSCLC) is one of the most devastating diseases worldwide. The study is aimed at identifying reliable prognostic biomarkers and to improve understanding of cancer initiation and progression mechanisms. RNA-Seq data were downloaded from The Cancer Genome Atlas (TCGA) database. Subsequently, comprehensive bioinformatics analysis incorporating gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and the protein-protein interaction (PPI) network was conducted to identify differentially expressed genes (DEGs) closely associated with NSCLC. Eight hub genes were screened out using Molecular Complex Detection (MCODE) and cytoHubba. The prognostic and diagnostic values of the hub genes were further confirmed by survival analysis and receiver operating characteristic (ROC) curve analysis. Hub genes were validated by other datasets, such as the Oncomine, Human Protein Atlas, and cBioPortal databases. Ultimately, logistic regression analysis was conducted to evaluate the diagnostic potential of the two identified biomarkers. Screening removed 1,411 DEGs, including 1,362 upregulated and 49 downregulated genes. Pathway enrichment analysis of the DEGs examined the Ras signaling pathway, alcoholism, and other factors. Ultimately, eight prioritized genes (GNGT1, GNG4, NMU, GCG, TAC1, GAST, GCGR1, and NPSR1) were identified as hub genes. High hub gene expression was significantly associated with worse overall survival in patients with NSCLC. The ROC curves showed that these hub genes had diagnostic value. The mRNA expressions of GNGT1 and NMU were low in the Oncomine database. Their protein expressions and genetic alterations were also revealed. Finally, logistic regression analysis indicated that combining the two biomarkers substantially improved the ability to discriminate NSCLC. GNGT1 and NMU identified in the current study may empower further discovery of the molecular mechanisms underlying NSCLC's initiation and progression.

Citing Articles

HPV, HBV, and HIV-1 Viral Integration Site Mapping: A Streamlined Workflow from NGS to Genomic Insights of Carcinogenesis.

Shen-Gunther J, Easley A Viruses. 2024; 16(6).

PMID: 38932267 PMC: 11209625. DOI: 10.3390/v16060975.


Supervised Parametric Learning in the Identification of Composite Biomarker Signatures of Type 1 Diabetes in Integrated Parallel Multi-Omics Datasets.

Bonnell J, Alcazar O, Watts B, Buchwald P, Abdulreda M, Ogihara M Biomedicines. 2024; 12(3).

PMID: 38540105 PMC: 10968313. DOI: 10.3390/biomedicines12030492.


Transcriptome profiling and metabolic pathway analysis towards reliable biomarker discovery in early-stage lung cancer.

Thirunavukkarasu M, Ramesh P, Karuppasamy R, Veerappapillai S J Appl Genet. 2024; 66(1):115-126.

PMID: 38443694 DOI: 10.1007/s13353-024-00847-2.


StackCirRNAPred: computational classification of long circRNA from other lncRNA based on stacking strategy.

Wang X, Liu Y, Li J, Wang G BMC Bioinformatics. 2022; 23(1):563.

PMID: 36575368 PMC: 9793644. DOI: 10.1186/s12859-022-05118-7.


Expression of , and in colon cancer and their influences on prognosis.

Chen D, Ye Z, Lew Z, Luo S, Yu Z, Lin Y Transl Cancer Res. 2022; 11(10):3572-3583.

PMID: 36388046 PMC: 9641087. DOI: 10.21037/tcr-22-1377.


References
1.
Qiao Y, Wang Z, Tan F, Chen J, Lin J, Yang J . Enhancer Reprogramming within Pre-existing Topologically Associated Domains Promotes TGF-β-Induced EMT and Cancer Metastasis. Mol Ther. 2020; 28(9):2083-2095. PMC: 7474343. DOI: 10.1016/j.ymthe.2020.05.026. View

2.
Han C, Choi B, Kim S, Sim S, Han S, Park B . Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor. Mol Ther Oncolytics. 2020; 17:293-305. PMC: 7191539. DOI: 10.1016/j.omto.2020.04.004. View

3.
Sucheston-Campbell L, Clay-Gilmour A, Barlow W, Budd G, Stram D, Haiman C . Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci. Pharmacogenet Genomics. 2017; 28(2):49-55. PMC: 5824720. DOI: 10.1097/FPC.0000000000000318. View

4.
Gao C, Sun X, Wu Z, Yuan H, Han H, Huang H . A Novel Benzofuran Derivative Moracin N Induces Autophagy and Apoptosis Through ROS Generation in Lung Cancer. Front Pharmacol. 2020; 11:391. PMC: 7235196. DOI: 10.3389/fphar.2020.00391. View

5.
Chen X, Wang Z, Tong F, Dong X, Wu G, Zhang R . lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer. Mol Ther Nucleic Acids. 2020; 19:643-653. PMC: 6965519. DOI: 10.1016/j.omtn.2019.10.047. View